Met Life Investment Management, LLC Adaptive Biotechnologies Corp Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 65,326 shares of ADPT stock, worth $399,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,326
Previous 65,326
-0.0%
Holding current value
$399,141
Previous $236,000
41.53%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ADPT
# of Institutions
202Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$183 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$88 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$71.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$70.9 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$65 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $873M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...